Home › Cystic Fibrosis › Michigan
Cystic Fibrosis clinical trials in Michigan
7 studies for Cystic Fibrosis are looking for participants at sites in Michigan.
Cities in Michigan
Phase 2 Study to Assess the Safety and Efficacy of ANG003
- University of Michigan, Michigan Medicine, Ann Arbor
- Wayne State University Harper University Hospital, Detroit
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07450547Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
- University of Michigan Health System, Ann Arbor
Recruiting
Ages 3 to 18 · All sexes · Updated Aug 3, 2026 · NCT06654752Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
- University of Michigan, Michigan Medicine, Ann Arbor
- Helen DeVos Children's Hospital, Grand Rapids
RecruitingObservational study
Up to age 10 · All sexes · Updated Jul 8, 2026 · NCT04509050Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- University of Michigan, Michigan Medicine, Ann Arbor
- Helen DeVos Children's Hospital, Grand Rapids
RecruitingPhase 4
Ages 6 and older · All sexes · Updated Jul 8, 2026 · NCT05548283Health Outcomes of Parents With Cystic Fibrosis-Aim 2
- University of Michigan, Ann Arbor
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 10, 2025 · NCT06296394Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
- University of Michigan, Ann Arbor
RecruitingObservational study
Ages 6 and older · All sexes · Updated Nov 3, 2025 · NCT06683092A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
- University of Michigan, Michigan Medicine, Ann Arbor
- Wayne State University Harper University Hospital, Detroit
- Corewell Health Helen DeVos, Grand Rapids
RecruitingObservational study
Ages 12 and older · All sexes · Updated Oct 1, 2025 · NCT06504589From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.